Unknown

Dataset Information

0

PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer.

ABSTRACT:

SUBMITTER: Roncolato F 

PROVIDER: S-EPMC6953296 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown PI3K/Akt/mTOR inhibitors in breast cancer.
| S-EPMC4706528 | biostudies-literature
Unknown Molecular alterations of PI3K/Akt/mTOR pathway: a therapeutic target in endometrial cancer.
| S-EPMC3913524 | biostudies-literature
Unknown PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors.
| S-EPMC3072168 | biostudies-literature
Unknown Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells.
| S-EPMC3413814 | biostudies-literature
Unknown Defining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors in breast cancer.
| S-EPMC3604032 | biostudies-literature
Unknown Targeting the PI3K/Akt/mTOR pathway in estrogen-receptor positive HER2 negative advanced breast cancer.
| S-EPMC7388095 | biostudies-literature
Unknown Complications of hyperglycaemia with PI3K-AKT-mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trials.
| S-EPMC4705886 | biostudies-other
Unknown Suppression of PI3K/Akt/mTOR/c-Myc/mtp53 Positive Feedback Loop Induces Cell Cycle Arrest by Dual PI3K/mTOR Inhibitor PQR309 in Endometrial Cancer Cell Lines.
| S-EPMC8616154 | biostudies-literature
Transcriptomics NCAPG promotes the proliferation and migration of endometrial cancer via the PI3K/AKT/mTOR signaling pathway
2023-12-01 | GSE220668 | GEO
Unknown Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer.
| S-EPMC8304822 | biostudies-literature